
Outgoing chief of the competition watchdog Andrea Coscelli has said he still has “anxiety” about the UK’s regulatory position.
Speaking on law firm Cleary Gottlieb’s new podcast, Coscelli praised the Competition Market Authority’s (CMA) approach to merger control, but was more critical of the antitrust function, pointing to the lengthy case times.
He said this was something the regulator was working on and the CMA was currently in the process of an ex-post assessment of merger controls.
“It is important for agencies to be open about previous mistakes,” he said.
Italian-born Coscelli also defended the CMA’s independence from the European Commission since Brexit, explaining that just because Big Tech firms like Meta may meet EU standards, it doesn’t necessarily mean they will automatically abide by the UK’s consumer standards.
He explained there was substantial “fragmentation” in the space, requiring UK protection.
Overall, he said the watchdog was in a better place now than it had been six years ago when he first took over the reins; the watchdog has since recruited a tide of tech and data science experts.
Coscelli pointed to the block of Sainsbury’s and Asda merger back in 2019 as a case he thought the CMA had handled well.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas